Rudolf Fuchshofer

Prof. Rudolf Fuchshofer

University Regensburg

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Experimental Eye Research
Verified
Journal Article
Closed access
KKKate E. Keller
Kate E. Keller
SBSanjoy K. Bhattacharya
Sanjoy K. Bhattacharya
TBTheresa Borrás
Theresa Borrás
TBThomas M. Brunner
Thomas M. Brunner
SCSunee Chansangpetch
Sunee Chansangpetch
WSW. Daniel Stamer
W. Daniel Stamer

19 November 2011 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
RFRudolf Fuchshofer
Rudolf Fuchshofer
ETErnst R. Tamm
Ernst R. Tamm

1 June 2012 in The American Journal of Pathology
Verified
Journal Article
Closed access
BJBenjamin Junglas
Benjamin Junglas
SKSabrina Kuespert
Sabrina Kuespert
ASAmin Seleem
Amin Seleem
TSTobias Struller
Tobias Struller
SUSabrina Ullmann
Sabrina Ullmann
RFRudolf Fuchshofer
Rudolf Fuchshofer

8 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DODarryl R. Overby
Darryl R. Overby
EZEnhua H. Zhou
Enhua H. Zhou
RVRocio Vargas-Pinto
Rocio Vargas-Pinto
RPRyan M. Pedrigi
Ryan M. Pedrigi
RFRudolf Fuchshofer
Rudolf Fuchshofer
MJMark Johnson
Mark Johnson
Significance: Glaucoma is a leading cause of blindness. The elevated intraocular pressure characteristic of many cases of glaucoma is attributable to increased resistance to aqueous humor outflow. However, the cause of this increased flow resistance has eluded investigators for over 140 y. Here we demonstrate that cells from the canal of Schlemm of glaucomatous eyes have altered gene expression and increased cytoskeletal stiffness that leads to reduced pore formation in these cells, likely accounting for increased outflow resistance associated with glaucoma. These findings thus establish that dysfunctional cytoskeletal mechanics may lie at the heart of this disease process and thereby motivate development of glaucoma therapeutics that target cell stiffness.

1 September 2015 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
BBBarbara M. Braunger
Barbara M. Braunger
RFRudolf Fuchshofer
Rudolf Fuchshofer
ETErnst R. Tamm
Ernst R. Tamm